|
Provalis focuses on diagnostic equipment and prescription drugs. Its Provalis Medical Diagnostics unit makes glucose monitors for diabetics, bone densitometers for osteoporosis, and other diagnostic equipment. Provalis continues some drug R&D work, focusing mainly on vaccines, using profits from its health care and diagnostic divisions to fund its work. The company has a contract with the US government to supply its Glycosal blood sugar monitors for a large diabetes study; it is also developing a home-use version of the product. In 2006 the company sold its Healthcare division for about $19 million to Kogen, an Ireland-based pharmaceutical group.
|
| | | Contact Information | |
Address: |
Newtech Sq., Deeside Industrial Park, 1st Ave., Zone 2
Deeside, Flintshire CH5 2NT, England
| | Phone: | +44-1244-288-888 | | Fax: | +44-1244-280-320 |
|
| Financial
Highlights | | Fiscal Year End: | June | | Revenue (2004): | 23.30 M | | Revenue Growth (1 yr): | 1.00% | | Employees (2004): | 110 | | Employee Growth (1 yr): | 2.80% |
|
|
Key People
| | • |
Interim CEO and Director:
Peter Woodford
|
|
|
